John W. Huemoeller II - May 6, 2021 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Stock symbol
AXIM
Transactions as of
May 6, 2021
Transactions value $
$0
Form type
4
Date filed
9/23/2022, 04:17 PM
Previous filing
Sep 23, 2022
Next filing
Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Disposed to Issuer $0 -2M -40% $0.00 3M May 6, 2021 Common Stock 2M $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 6, 2021, Reporting Person voluntarily agreed to cancel the option to purchase 2,000,000 shares of the Issuer's common stock granted to Reporting Person on January 2, 2019.